VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ERIC 2022 | The use of AI for analyzing genetic and molecular data in CLL

Andreas Agathangelidis, PhD, Center for Research and Technology Hellas, Thermi, Greece, discusses the emergent use of artificial intelligence (AI) in chronic lymphocytic leukemia (CLL). Dr Agathangelidis explains how applying a different approach in analyzing molecular data could help generate novel findings in CLL. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter